EP 1909689 A4 20111116 - DRUG-CONTAINING IMPLANTS AND METHODS OF USE THEREOF
Title (en)
DRUG-CONTAINING IMPLANTS AND METHODS OF USE THEREOF
Title (de)
ARZNEIHALTIGE IMPLANTATE UND ANWENDUNGSVERFAHREN DAFÜR
Title (fr)
IMPLANTS CONTENANT UN MEDICAMENT ET LEUR PROCEDE D'UTILISATION
Publication
Application
Priority
- US 2006027894 W 20060718
- US 18323205 A 20050718
- US 19584505 A 20050803
Abstract (en)
[origin: WO2007011955A2] The present invention provides implants comprising a therapeutic drug and a polymer containing polylactic acid (PLA) and optionally polyglycolic acid (PGA). The present invention also provides methods of maintaining a therapeutic level of a drug in a subject, releasing a therapeutic drug at a substantially linear rate, and treating schizophrenia and other diseases and disorders, utilizing implants of the present invention.
IPC 8 full level
A61K 9/00 (2006.01); A61F 2/00 (2006.01); A61K 47/34 (2006.01)
CPC (source: EP KR)
A61F 2/00 (2013.01 - KR); A61K 9/0024 (2013.01 - EP); A61K 31/192 (2013.01 - EP); A61K 31/445 (2013.01 - EP); A61K 31/519 (2013.01 - EP); A61K 31/549 (2013.01 - EP); A61K 31/573 (2013.01 - EP); A61K 31/60 (2013.01 - EP); A61K 47/34 (2013.01 - EP); A61L 27/18 (2013.01 - EP); A61L 27/54 (2013.01 - EP); A61P 1/08 (2017.12 - EP); A61P 7/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 15/18 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP); A61L 2300/222 (2013.01 - EP); A61L 2300/402 (2013.01 - EP); A61L 2300/41 (2013.01 - EP); A61L 2300/604 (2013.01 - EP)
C-Set (source: EP)
Citation (search report)
- [XP] WO 2005070332 A1 20050804 - UNIV PENNSYLVANIA [US], et al
- [XI] US 2002179096 A1 20021205 - SIEGEL STEVEN J [US], et al
- [XI] WO 9513814 A1 19950526 - JANSSEN PHARMACEUTICA NV [BE], et al
- [XI] SIEGEL STEVEN J ET AL: "Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia", NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHING, NEW YORK, NY, US, vol. 26, no. 6, 1 June 2002 (2002-06-01), pages 817 - 823, XP002633817, ISSN: 0893-133X
- See references of WO 2007011955A2
Citation (examination)
- WO 2006078320 A2 20060727 - BROOKWOOD PHARMACEUTICALS INC [US], et al
- WO 2007041410 A2 20070412 - ALZA CORP [US], et al
- STEVEN J SIEGEL ET AL: "Surgically implantable long-term delivery systems for atypical antipsychotic medications", NEUROPSYCHOPHARMACOLOGY., vol. 29, no. S1, 1 December 2004 (2004-12-01), US, pages S226, XP055299878, ISSN: 0893-133X
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2007011955 A2 20070125; WO 2007011955 A3 20071213; AU 2006269927 A1 20070125; AU 2006269927 B2 20130516; CA 2614601 A1 20070125; CA 2614601 C 20150407; CN 103637977 A 20140319; EP 1909689 A2 20080416; EP 1909689 A4 20111116; JP 2009501798 A 20090122; JP 2014001246 A 20140109; JP 2015078233 A 20150423; JP 5405825 B2 20140205; JP 6153952 B2 20170628; KR 101283946 B1 20130715; KR 20080033991 A 20080417; MX 2008000573 A 20080314; MX 362908 B 20190221
DOCDB simple family (application)
US 2006027894 W 20060718; AU 2006269927 A 20060718; CA 2614601 A 20060718; CN 201310587181 A 20060718; EP 06787745 A 20060718; JP 2008522903 A 20060718; JP 2013210074 A 20131007; JP 2015010783 A 20150123; KR 20087003822 A 20060718; MX 2008000573 A 20060718; MX 2014012310 A 20060718